Trial
NCT00003485
Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Burzynski Research Institute
Collaborators
—
Condition
Colon Cancer
Intervention
antineoplaston A10, antineoplaston AS2-1 (ANP)
Why stopped
slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-09-28